404
Participants
Start Date
March 31, 2006
Primary Completion Date
September 30, 2008
Study Completion Date
September 30, 2008
Placebo
Matching Placebo
Ropinirole
Ropinirole IR 0.25mg/day to 4mg/day for RLS
GSK Investigational Site, Camperdown
GSK Investigational Site, Hamar
GSK Investigational Site, East Melbourne
GSK Investigational Site, Bern
GSK Investigational Site, Clayton
GSK Investigational Site, Kippa-Ring
GSK Investigational Site, Odense C
GSK Investigational Site, Woodville
GSK Investigational Site, Vejle
GSK Investigational Site, Zurich
GSK Investigational Site, Aalborg
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Schwerin
GSK Investigational Site, San Sebastián
GSK Investigational Site, Westerstede
GSK Investigational Site, Pavia
GSK Investigational Site, Madrid
GSK Investigational Site, Marburg
GSK Investigational Site, Bologna
GSK Investigational Site, Munich
GSK Investigational Site, Regensburg
GSK Investigational Site, Bamberg
GSK Investigational Site, Olomouc
GSK Investigational Site, Ostrava
GSK Investigational Site, Pardubice
GSK Investigational Site, Prague
GSK Investigational Site, Rome
GSK Investigational Site, Coimbra
GSK Investigational Site, Lisbon
GSK Investigational Site, Bratislava
GSK Investigational Site, Bratislava
GSK Investigational Site, Dubnica nad Váhom
GSK Investigational Site, Levoča
GSK Investigational Site, Žilina
GSK Investigational Site, Barcelona
GSK Investigational Site, Avesta
GSK Investigational Site, Gothenburg
GSK Investigational Site, Örebro
Lead Sponsor
GlaxoSmithKline
INDUSTRY